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Abstract
Radiology has not been spared in recent economic crises with a substantial reduction in the turnover of imaging equipment. These
problems are exacerbated by increasing demand for healthcare across Europe. Therefore, using existing radiological services
while rigorously following evidence-based guidelines might improve patient care. Thus, diagnostic pathways should be assessed
not only for technical and diagnostic performance but also for their impact onmedical and social outcome. In this paper, we report
the advice of the Research Committee of ESSR on how we may guide musculoskeletal radiological research towards studies that
have useful clinical impact. The ESSR Research Committee intends to encourage research with potential to influence treatment,
patient outcome, and social impact.
Key Points
• Research in medical imaging has the potential to improve human health.
• High-level studies have the potential to place radiology at the pinnacle of quality in evidence-based practice.
• The ESSR Research Committee intends to encourage research with potential to influence treatment, patient outcome, and social
impact.
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Radiology has not been spared in recent economic crises with a
substantial reduction in the turnover of imaging equipment [1].
These problems are exacerbated by increasing demand for
healthcare across Europe. New developments in medical sci-
ences and technology combine with an aging population to
increase overall demand [1]. Current provision of imaging does
not seem sustainable and practice is likely to be modified in the
next few years. However, it is not axiomatic that these changes
will lead to worse outcome. For example, there are many areas
of medicine where not testing, not imaging, and not treating
could result in better health outcomes [2]. Indeed, providing
more services has not implied a direct improvement of health
measures in some areas [3]. Thus, diagnostic pathways should
be assessed not only for technical and diagnostic performance
but also for their impact on medical and social outcome. John
R. Thornbury advocated this concept in 1994, suggesting that
radiologists should have a strong commitment not only in tech-
nology assessment but also in outcome research [4]. This
should include a multidisciplinary approach involving the re-
ferring physicians and other key personnel in the research [4,
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5]. The mission and vision of the European Society of
Musculoskeletal Radiology (ESSR) describes the develop-
ment, distribution, and cost-effective implementation of state-
of-the-art radiological concepts to benefit patients [6, 7].
In this paper, we present the opinion of the Research
Committee of ESSR considering how we may guide muscu-
loskeletal radiological research towards studies with an added
clinical value.
According to Medina and Blackmore, only a third of im-
aging practice is supported by scientific evidence [8]. Other
authors estimate that well-conducted randomized controlled
trials, meta-analyses, or systematic reviews are available for
less than 10% of standard imaging procedures [9, 10]. An
internal analysis of the ESSR 2008–2016 annual meetings
concluded that most musculoskeletal radiological research
falls into the two lower levels of the Thornbury scale
(Tables 1 and 2). Not surprisingly, only a few studies were
likely to influence therapy, patient outcome, or social impact.
The Thornbury scale is a one-way logical chain where a pos-
itive effect at any level generally implies a positive effect at
lower levels but not vice versa [10]. Consequently, a new
diagnostic technology with a positive impact on patient out-
come may have better technical and diagnostic performances
compared with standard technology. Conversely, there is no
certainty that a radiologic test with a higher diagnostic perfor-
mance results in better patient outcome [8–10]. The strong
potential of musculoskeletal radiology to have clinical impact
is demonstrated by those studies on interventional techniques
or procedures (Tables 3 and 4). Interventional radiology has a
pivotal role in patient care.
Indeed, the importance on patients’ impact of musculo-
skeletal radiology may have been underestimated in the
Table 1 Hierarchy of studies on diagnostic tests. From reference [4] and from Sardanelli F, Di Leo G (2008) Biostatistics for radiologists. Springer,
Milan, pp. 165–179
Level Parameters under investigation
6. Societal impact Benefit–cost and cost-effectiveness analysis from a social perspective
5. Patient outcomes Fraction of patients improved with the test compared with that of those improved without the test; difference in
morbidity between the patients with the test and those without the test; gain in quality-adjusted life years (QALYs)
obtained by the patients with the test compared with those without the test
4. Therapeutic impact Fraction of patients for whom the test is judged useful for treatment planning or for whom the treatment planning is
modified on the basis of the information supplied by the test
3. Diagnostic impact Fraction of patients for whom the test is judged useful for rendering the diagnosis or for whom the diagnosis is
substantially modified after the test; positive and negative likelihood ratios
2. Diagnostic performance Sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and receiver operator characteristic
(ROC) analysis; intraobserver, interobserver, and interstudy reproducibility
1. Technical performance Gray-scale range; modulation transfer function; sharpness; spatial resolution, in-plane (line pairs per mm, pixel size) and
through-the-plane (slice thickness), integrated in voxel size; signal-to-noise ratio; contrast resolution
(contrast-to-noise ratio); time resolution (images/s), etc.
Table 2 Number of abstracts
according to the modified
Thornbury scale per year
Year of
ESSR
congress
Total
number of
abstracts
1. Technical
performance
2.
Diagnostic
performance
3.
Diagnostic
impact
4.
Therapeutic
impact
5. Patient
outcomes
6.
Social
Impact
2008 35 14 (40%) 11 (31%) 2 (6%) 7 (20%) 1 (3%) –
2009 37 20 (54%) 10 (27%) 5 (15%) 1 (3%) 1 (3%) –
2010 42 20 (48%) 13 (31%) 3 (7%) 6 (14%) – –
2011 25 13 (52%) 11 (44%) – – 1 (4%) –
2012 48 15 (31%) 25 (52%) 8 (17%) – – –
2013 40 18 (45%) 12 (30%) 2 (5%) 8 (20%) – –
2014 48 25 (52%) 11 (23%) 3 (6%) 9 (19%) – –
2015 30 15 (50%) 6 (20%) 5 (17%) 4 (13%) – –
2016 29 21 (73%) 7 (24%) 1 (3%) – – –
Total 334 161 (48%) 106 (32%) 29 (9%) 35 (10%) 3 (1%) –
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past, having probably been considered lower than that in
other life-threatening conditions. However, there are quite
a few areas of musculoskeletal radiology that deserve spe-
cial attention. One topic of high interest is certainly
sarcopenia, which is a chronic condition characterized by
progressive loss of skeletal muscle mass typically occur-
ring with aging [11]. The clinical implication of this con-
dition is tremendous, as it has been estimated to affect over
32 million people in the European Union by 2045, with
22.3% prevalence among elderly. Sarcopenia leads both
to muscle weakness (and in turn to increased fracture risk)
and increased morbidity and mortality in patients undergo-
ing surgery, thus representing a high societal burden. In
this setting, radiological research has the chance of playing
a major role, especially in finding a reliable, non-invasive
method for opportunistic screening of this silent disease
[12] with both conventional and non-conventional
methods [13]. Another very important field of action is
represented by osteoarthritis, affecting more than 24 mil-
lion people in the USA with prevalence increasing with
aging population. Patients do not die from osteoarthritis,
but joint pain, which is the most common symptom, leads
to major disability, reduced mobility, and ultimately an
increase of major cardiovascular events [14]. In this set-
ting, musculoskeletal radiology may play a central role,
finding quick and inexpensive methods to detect joint dam-
age even before it becomes clinically evident. These are
only two examples of how musculoskeletal radiology
may really make the difference in patients’ outcome.
The spectrum of ESSR research to date demonstrates a
need to balance technical and “impact” research, especially
when financial and human resources are limited. We are
aware that high-level studies are time- and resource-
consuming when compared with simpler investigations,
but they have the potential to put radiology at the upper
end of quality in evidence-based practice. However, the
traditional concept that randomized controlled trials are
one of the best methods to yield valid scientific evidence
is being questioned [15] and we should keep an open mind.
Current European financial limitations are likely to restrict
new technology and the radiology research may be better di-
rected to the study of therapeutic impact, patient outcome, and
social impact in an environment where there is a reduction in
provision of new techniques. There is the potential to arrange
and coordinate fixed protocol long-term studies of technical
advances. The European Community has assigned some re-
sources to the assessment of “the effectiveness of existing
healthcare interventions in the adult population” through the
Horizon 2020 Working Programme [16]. The goal of the
European Commission is to address many challenges to society
through more effective prevention, diagnosis, and treatment.
Thus, the ESSR Research Committee intends to encourage re-
search with potential to influence treatment, patient outcome,
and social impact.
Table 3 Distribution of level 4 and
level 5 abstracts according to
radiological technique used. Note
that when more than one technique
was used, one point was assigned to
each of the technique involved. For
this reason, the sum of the values
reported in this table is higher than
those reported in Table 2
Technique Level of modified Thornbury scale
4. Therapeutic impact 5. Patient outcomes
Ultrasound 18 1
Magnetic resonance imaging 3
Computed tomography 6 1
Interventional procedures (US + CT + x-ray) 30 3*
Others (tomosynthesis, PET-MRI, PET-CT, fluoroscopy, etc.) 4 1
*Level 5 abstracts were related to interventional procedures
Table 4 Overview of abstracts related to interventional procedures
Level of modified Thornbury scale
Total number of
abstracts
1 Technical
performance
2.Diagnostic
performance
3.Diagnostic
impact
4.Therapeutic
impact
5. Patient
outcomes
6. Social
impact
Interventional
procedures
73 15 (21%) 9 (12%) 16 (22%) 30 (41%) 3 (4%) –
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